Sunday 24 November 2024

The Pharma Letter Podcast — Episode 13 — Is there a data capture crisis in biotech?

Biotechnology
Simon Wentworth
5 April 2022
thepharmaletterpodcast-episode13-1

More on this story...

Pharmaceutical
Increasing number of ATPM clinical trials in the UK
17 January 2023
Biotechnology
The Pharma Letter Podcast — Episode 9 — The rise of AI in drug discovery
30 December 2021
Pharmaceutical
The Pharma Letter Podcast — Episode 10 — Will decentralized clinical trials become the new standard?
10 February 2022
Biotechnology
Major entrant in biotech discovery could shake up existing order
6 May 2022


More ones to watch >


Today's issue

Otsuka gains global licensing rights from Ionis to ulefnersen
Pharmaceutical
Otsuka gains global licensing rights from Ionis to ulefnersen
23 November 2024
Biotechnology
Anti-CD20 MAb Rituxan approved for ITP in Japan
23 November 2024
Biotechnology
J&J powers on with Tremfya with UC SC filing
22 November 2024
Biotechnology
Takeda launches Fruzaqla in Japan
22 November 2024
Biotechnology
CStone out-licenses sugemalimab rights in MENA region
22 November 2024
Biotechnology
China's regulator to review Akeso's checkpoint blocker
22 November 2024
Biotechnology
Paragon Therapeutics appoints first chief executive
22 November 2024

Company Spotlight

A Dutch clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.




More Features in Biotechnology

Anti-CD20 MAb Rituxan approved for ITP in Japan
23 November 2024
J&J powers on with Tremfya with UC SC filing
22 November 2024
Takeda launches Fruzaqla in Japan
22 November 2024
CStone out-licenses sugemalimab rights in MENA region
22 November 2024


Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze